SOX2 and breast carcinoma: One of the lncRNA, SOX2 has been identified in 43% of basal cell-like breast cancers [25], and it is significantly associated with CK5/6, EGFR, and vimentin immunoreactivity, while showing an inverse association with estrogen and progesterone receptor status [26].